Allergen immunotherapy for the treatment of respiratory allergies in the elderly

Gyu Young Hur, Ji Ho Lee, Hae Sim Park

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Purpose of review: Respiratory allergies, including asthma and allergic rhinitis can also occur in the elderly. Allergen immunotherapy for allergic diseases is the only disease-modifying treatment for patients with allergies available thus far. Here, we review current evidence supporting the use of allergen immunotherapy in the elderly and discuss its efficacy and utility for the treatment of respiratory allergic diseases in this setting. Recent findings: Subcutaneous and/or sublingual immunotherapy are effective therapeutic options in not only young but also older patients. Allergen immunotherapy reduces medication and symptom scores in the elderly and can thus be safely prescribed in this population. Summary: Elderly individuals with proven, clinically relevant immunoglobulin E sensitization to inhalant allergens may benefit from allergen immunotherapy for respiratory allergic diseases. Older patients without contraindications should therefore be considered for treatment, with the additional benefit of reduced medication and symptom scores.

Original languageEnglish
Pages (from-to)304-308
Number of pages5
JournalCurrent Opinion in Allergy and Clinical Immunology
Volume17
Issue number4
DOIs
Publication statusPublished - 2017 Aug 1

Fingerprint

Immunologic Desensitization
Hypersensitivity
Sublingual Immunotherapy
Therapeutics
Allergens
Immunoglobulin E
Asthma
Population

Keywords

  • allergen immunotherapy
  • allergic rhinitis
  • asthma
  • elderly

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Allergen immunotherapy for the treatment of respiratory allergies in the elderly. / Hur, Gyu Young; Lee, Ji Ho; Park, Hae Sim.

In: Current Opinion in Allergy and Clinical Immunology, Vol. 17, No. 4, 01.08.2017, p. 304-308.

Research output: Contribution to journalReview article

@article{609c1fd033d84a219ae44c30c852d561,
title = "Allergen immunotherapy for the treatment of respiratory allergies in the elderly",
abstract = "Purpose of review: Respiratory allergies, including asthma and allergic rhinitis can also occur in the elderly. Allergen immunotherapy for allergic diseases is the only disease-modifying treatment for patients with allergies available thus far. Here, we review current evidence supporting the use of allergen immunotherapy in the elderly and discuss its efficacy and utility for the treatment of respiratory allergic diseases in this setting. Recent findings: Subcutaneous and/or sublingual immunotherapy are effective therapeutic options in not only young but also older patients. Allergen immunotherapy reduces medication and symptom scores in the elderly and can thus be safely prescribed in this population. Summary: Elderly individuals with proven, clinically relevant immunoglobulin E sensitization to inhalant allergens may benefit from allergen immunotherapy for respiratory allergic diseases. Older patients without contraindications should therefore be considered for treatment, with the additional benefit of reduced medication and symptom scores.",
keywords = "allergen immunotherapy, allergic rhinitis, asthma, elderly",
author = "Hur, {Gyu Young} and Lee, {Ji Ho} and Park, {Hae Sim}",
year = "2017",
month = "8",
day = "1",
doi = "10.1097/ACI.0000000000000370",
language = "English",
volume = "17",
pages = "304--308",
journal = "Current Opinion in Allergy and Clinical Immunology",
issn = "1528-4050",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Allergen immunotherapy for the treatment of respiratory allergies in the elderly

AU - Hur, Gyu Young

AU - Lee, Ji Ho

AU - Park, Hae Sim

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Purpose of review: Respiratory allergies, including asthma and allergic rhinitis can also occur in the elderly. Allergen immunotherapy for allergic diseases is the only disease-modifying treatment for patients with allergies available thus far. Here, we review current evidence supporting the use of allergen immunotherapy in the elderly and discuss its efficacy and utility for the treatment of respiratory allergic diseases in this setting. Recent findings: Subcutaneous and/or sublingual immunotherapy are effective therapeutic options in not only young but also older patients. Allergen immunotherapy reduces medication and symptom scores in the elderly and can thus be safely prescribed in this population. Summary: Elderly individuals with proven, clinically relevant immunoglobulin E sensitization to inhalant allergens may benefit from allergen immunotherapy for respiratory allergic diseases. Older patients without contraindications should therefore be considered for treatment, with the additional benefit of reduced medication and symptom scores.

AB - Purpose of review: Respiratory allergies, including asthma and allergic rhinitis can also occur in the elderly. Allergen immunotherapy for allergic diseases is the only disease-modifying treatment for patients with allergies available thus far. Here, we review current evidence supporting the use of allergen immunotherapy in the elderly and discuss its efficacy and utility for the treatment of respiratory allergic diseases in this setting. Recent findings: Subcutaneous and/or sublingual immunotherapy are effective therapeutic options in not only young but also older patients. Allergen immunotherapy reduces medication and symptom scores in the elderly and can thus be safely prescribed in this population. Summary: Elderly individuals with proven, clinically relevant immunoglobulin E sensitization to inhalant allergens may benefit from allergen immunotherapy for respiratory allergic diseases. Older patients without contraindications should therefore be considered for treatment, with the additional benefit of reduced medication and symptom scores.

KW - allergen immunotherapy

KW - allergic rhinitis

KW - asthma

KW - elderly

UR - http://www.scopus.com/inward/record.url?scp=85019898496&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019898496&partnerID=8YFLogxK

U2 - 10.1097/ACI.0000000000000370

DO - 10.1097/ACI.0000000000000370

M3 - Review article

C2 - 28525399

AN - SCOPUS:85019898496

VL - 17

SP - 304

EP - 308

JO - Current Opinion in Allergy and Clinical Immunology

JF - Current Opinion in Allergy and Clinical Immunology

SN - 1528-4050

IS - 4

ER -